Bronson Crouch
Amministratore Delegato presso INSTIL BIO, INC.
Patrimonio netto: 22 M $ in data 30/04/2024
Profilo
Bronson Crouch is currently the Chairman & Chief Executive Officer at Instil Bio, Inc. He is also a Managing Partner at Peloton Therapeutics, Inc., TCR2 Therapeutics, Inc., and iTeos Therapeutics, Inc. Additionally, he is a Founding Partner at Curative Ventures Management LLC.
Previously, he was a Managing Partner at CoStim Pharmaceuticals, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INSTIL BIO, INC.
32.99% | 16/04/2024 | 2 145 895 ( 32.99% ) | 22 M $ | 30/04/2024 |
Posizioni attive di Bronson Crouch
| Società | Posizione | Inizio |
|---|---|---|
| INSTIL BIO, INC. | Amministratore Delegato | 01/11/2018 |
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | - |
| PELOTON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| ITEOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Curative Ventures Management LLC
 Curative Ventures Management LLC Investment ManagersFinance Curative Ventures Management LLC (Curative Ventures) is a venture capital firm founded in 2010. The firm is headquartered in Dallas, Texas. | Investitore di Private Equity | 01/01/2014 |
Precedenti posizioni note di Bronson Crouch
| Società | Posizione | Fine |
|---|---|---|
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Curative Ventures Management LLC
Curative Ventures Management LLC Investment ManagersFinance Curative Ventures Management LLC (Curative Ventures) is a venture capital firm founded in 2010. The firm is headquartered in Dallas, Texas. | Finance |
- Borsa valori
- Insiders
- Bronson Crouch
